Literature DB >> 15731079

Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis.

B C Fries1, S C Lee, R Kennan, W Zhao, A Casadevall, D L Goldman.   

Abstract

Increased intracranial pressure (ICP) plays an important role in the morbidity and mortality of cryptococcal meningoencephalitis. The microbial and host factors that contribute to the development of increased ICP are poorly understood. We found that phenotypic switch variants of Cryptococcus neoformans (smooth and mucoid) differed in their abilities to promote increased ICP in a rat model of cryptococcal meningitis. Rats infected with the mucoid variant developed increased ICP, whereas rats infected with the smooth parent did not. This trend correlated with a shorter survival time and a higher cerebrospinal fluid (CSF) fungal burden for mucoid variant-infected rats, although brain fungal burdens were comparable between mucoid variant- and smooth parent-infected rats. Magnetic resonance imaging revealed enhanced T2 signal intensity over the surfaces of the brains of mucoid variant-infected rats. In addition, more polysaccharide accumulated in the CSF and brains of mucoid variant-infected rats. The accumulation of glucorunoxylomannan was associated with elevated levels of MCP-1 (CCL2) and, accordingly, a more pronounced but ineffective monocytic inflammatory response in the meninges of mucoid variant-infected rats. In summary, these findings suggest that strain-specific characteristics can influence the development of increased ICP and indicate a manner in which phenotypic switching could influence the outcome of a central nervous system infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731079      PMCID: PMC1064965          DOI: 10.1128/IAI.73.3.1779-1787.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  Phenotypic switching in Cryptococcus neoformans.

Authors:  Bettina C Fries; David L Goldman; Arturo Casadevall
Journal:  Microbes Infect       Date:  2002-11       Impact factor: 2.700

2.  Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.

Authors:  P G Pappas; J R Perfect; G A Cloud; R A Larsen; G A Pankey; D J Lancaster; H Henderson; C A Kauffman; D W Haas; M Saccente; R J Hamill; M S Holloway; R M Warren; W E Dismukes
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

Review 3.  Immunoregulation by capsular components of Cryptococcus neoformans.

Authors:  A Vecchiarelli
Journal:  Med Mycol       Date:  2000-12       Impact factor: 4.076

4.  Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure.

Authors:  B C Fries; D L Goldman; R Cherniak; R Ju; A Casadevall
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection.

Authors:  B C Fries; C P Taborda; E Serfass; A Casadevall
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

6.  Antibody interactions with the capsule of Cryptococcus neoformans.

Authors:  M Feldmesser; J Rivera; Y Kress; T R Kozel; A Casadevall
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis.

Authors:  M M Lipovsky; L Tsenova; F E Coenjaerts; G Kaplan; R Cherniak; A I Hoepelman
Journal:  J Neuroimmunol       Date:  2000-11-01       Impact factor: 3.478

8.  Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis.

Authors:  S C Lee; A Casadevall; D W Dickson
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

Review 9.  Cryptococcosis.

Authors:  John R Perfect; Arturo Casadevall
Journal:  Infect Dis Clin North Am       Date:  2002-12       Impact factor: 5.982

10.  Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia.

Authors:  Fabrice Chrétien; Olivier Lortholary; Imad Kansau; Ségolène Neuville; Françoise Gray; Françoise Dromer
Journal:  J Infect Dis       Date:  2002-08-02       Impact factor: 5.226

View more
  16 in total

Review 1.  Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans.

Authors:  Neena Jain; Abraham Guerrero; Bettina C Fries
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

2.  Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Authors:  Neena Jain; Li Li; Ye-Ping Hsueh; Abraham Guerrero; Joseph Heitman; David L Goldman; Bettina C Fries
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

Review 3.  Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis.

Authors:  Gunjan Gupta; Bettina C Fries
Journal:  Future Microbiol       Date:  2010-05       Impact factor: 3.165

Review 4.  Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii.

Authors:  Neena Jain; Bettina C Fries
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

Review 5.  Cryptococcal Disease in HIV-Infected Children.

Authors:  Carol Kao; David L Goldman
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

Review 6.  Antigenic and phenotypic variations in fungi.

Authors:  Neena Jain; Bettina C Fries
Journal:  Cell Microbiol       Date:  2009-09-21       Impact factor: 3.715

7.  Phenotypic Switching in Fungi.

Authors:  Neena Jain; Fahmi Hasan; Bettina C Fries
Journal:  Curr Fungal Infect Rep       Date:  2008-09-01

8.  Allergen1 regulates polysaccharide structure in Cryptococcus neoformans.

Authors:  Neena Jain; Radames J B Cordero; Arturo Casadevall; Bettina C Fries
Journal:  Mol Microbiol       Date:  2013-04-09       Impact factor: 3.501

9.  EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans.

Authors:  Emma J Robertson; Julie M Wolf; Arturo Casadevall
Journal:  Appl Environ Microbiol       Date:  2012-08-31       Impact factor: 4.792

Review 10.  Aging as an emergent factor that contributes to phenotypic variation in Cryptococcus neoformans.

Authors:  Tejas Bouklas; Bettina C Fries
Journal:  Fungal Genet Biol       Date:  2014-10-13       Impact factor: 3.495

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.